competition?, page-4

"Animals and humans will "perceive" the chemical structure of SBG as being alien to the body, and when SBG comes in contact with immune cells, for instance in wounds, it will therefore elicit and enhance a number of natural defense and repair mechanisms."

I feel that the risk to TIS is likely low (I'm biased though). The inflammatory/immune response method that this company appears to be using is being used by another company (somebody might be able to remember it) that used microspheres instead of SBG. I recall that this treatment was purported to be painful.